Parexel that is a leading provider of Clinical, Commercial and Consulting solutions has announced today that it will be appointing Makoto Sugita as their Senior Vice President and General Manager for their Japan Organization. Dr. Sugita shall be leading the Japanese organization of Parexel for delivering some quality service to their clients in this very fast-growing sector.
The Executive Vice President, Gadi Saarony said that Makoto will bring to Parexel over 25 years of experience in medicine, along with leading successfully a clinical R&D in the Asian/Pacific region. He further added that his comprehensive understanding of Research and Development accompanied by the experience of leading worldwide clinical development teams and programs, and the width of regulatory expertise shall be of immense value to Parexel as they continue to construct their presence in this growing and important area for the development of drugs. Japan is continuing to be a progressively significant and a market of priority for their customers and they feel thrilled having Makoto on board in order to lead their local presence as they partner with their customers to proceed the development of innovative therapies throughout the world.
Prior to joining Parexel, Mr. Sugita had held various positions of leadership with Johnson and Johnson and Janssen. In the year of 2018 alone, he conducted over 130 clinical studies in more than 16 different franchises of clinics and almost 60 new launches of products. Before this role, Dr. Sugita was serving as the Vice President and Head of Medical Affairs as well as Clinical Research for Johnson and Johnson Medical Devices in the Asian and Pacific region.